EP2912161A4 - METHODS AND SYSTEMS FOR ESTIMATING NUTRITIONAL NEEDS OF HUMAN PATIENTS AND OTHER PATIENTS AND FOR MANAGING SUCH NUTRITIONAL NEEDS - Google Patents

METHODS AND SYSTEMS FOR ESTIMATING NUTRITIONAL NEEDS OF HUMAN PATIENTS AND OTHER PATIENTS AND FOR MANAGING SUCH NUTRITIONAL NEEDS

Info

Publication number
EP2912161A4
EP2912161A4 EP13848522.2A EP13848522A EP2912161A4 EP 2912161 A4 EP2912161 A4 EP 2912161A4 EP 13848522 A EP13848522 A EP 13848522A EP 2912161 A4 EP2912161 A4 EP 2912161A4
Authority
EP
European Patent Office
Prior art keywords
nutritional needs
patients
human
systems
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP13848522.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2912161A2 (en
Inventor
Michael Horning
George Brooks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Run Them Sweet LLC
Original Assignee
Run Them Sweet LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/903,936 external-priority patent/US9557334B2/en
Priority claimed from US14/043,703 external-priority patent/US9232815B2/en
Priority claimed from US14/061,640 external-priority patent/US9897609B2/en
Application filed by Run Them Sweet LLC filed Critical Run Them Sweet LLC
Priority to EP19151852.1A priority Critical patent/EP3505167A1/en
Publication of EP2912161A2 publication Critical patent/EP2912161A2/en
Publication of EP2912161A4 publication Critical patent/EP2912161A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP13848522.2A 2012-10-25 2013-10-24 METHODS AND SYSTEMS FOR ESTIMATING NUTRITIONAL NEEDS OF HUMAN PATIENTS AND OTHER PATIENTS AND FOR MANAGING SUCH NUTRITIONAL NEEDS Ceased EP2912161A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19151852.1A EP3505167A1 (en) 2012-10-25 2013-10-24 Support of nutritional needs of human and other patients

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201261795819P 2012-10-25 2012-10-25
US13/903,936 US9557334B2 (en) 2012-10-25 2013-05-28 Formulations and methods to provide nutrition to human and other patients
US13/903,939 US9500657B2 (en) 2012-10-25 2013-05-28 Formulations containing labels for medical diagnostics
US13/903,929 US9808031B2 (en) 2012-10-25 2013-05-28 Systems and methods to estimate nutritional needs of human and other patients
US13/957,813 US8927490B2 (en) 2012-10-25 2013-08-02 Systems and methods to estimate nutritional needs of human and other patients
US13/957,977 US20140120238A1 (en) 2012-10-25 2013-08-02 Formulations and methods to provide nutrition to human and other patients
US13/957,872 US20140121270A1 (en) 2012-10-25 2013-08-02 Formulations and methods to provide nutrition to human and other patients
US14/043,703 US9232815B2 (en) 2012-10-25 2013-10-01 Blood lactate range targets and nutritional formulations and protocols to support patients
US14/061,640 US9897609B2 (en) 2012-10-25 2013-10-23 Systems and apparatus to estimate nutritional needs of human and other patients and to support such nutritional needs
PCT/US2013/066597 WO2014066628A2 (en) 2012-10-25 2013-10-24 Methods and systems to estimate nutritional needs of human and other patients and to support such nutritional needs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP19151852.1A Division EP3505167A1 (en) 2012-10-25 2013-10-24 Support of nutritional needs of human and other patients

Publications (2)

Publication Number Publication Date
EP2912161A2 EP2912161A2 (en) 2015-09-02
EP2912161A4 true EP2912161A4 (en) 2016-08-24

Family

ID=53056453

Family Applications (2)

Application Number Title Priority Date Filing Date
EP13848522.2A Ceased EP2912161A4 (en) 2012-10-25 2013-10-24 METHODS AND SYSTEMS FOR ESTIMATING NUTRITIONAL NEEDS OF HUMAN PATIENTS AND OTHER PATIENTS AND FOR MANAGING SUCH NUTRITIONAL NEEDS
EP19151852.1A Withdrawn EP3505167A1 (en) 2012-10-25 2013-10-24 Support of nutritional needs of human and other patients

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP19151852.1A Withdrawn EP3505167A1 (en) 2012-10-25 2013-10-24 Support of nutritional needs of human and other patients

Country Status (6)

Country Link
EP (2) EP2912161A4 (ko)
JP (2) JP2016502654A (ko)
KR (1) KR102172971B1 (ko)
AU (2) AU2013334526B2 (ko)
CA (1) CA2889348A1 (ko)
WO (1) WO2014066628A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170156386A1 (en) * 2014-05-21 2017-06-08 Nestec S.A. System, process and device for producing a nutritional composition with personalized nutrient content
US10768169B2 (en) * 2015-01-23 2020-09-08 Societe Des Produits Nestle S.A. Method for determining the distinctive nutritional requirements of a patient

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275136A1 (en) * 2005-05-25 2008-11-06 Alain Grynberg Use of Glycerol for Improving Cardiac Function
US20090285909A1 (en) * 2006-04-03 2009-11-19 Leverve Xavier M Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420107A (en) 1990-01-26 1995-05-30 Brooks; George A. Method and composition for energy source supplementation during exercise and recovery
US5910403A (en) * 1997-05-15 1999-06-08 The Regents Of University Of California Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
US6329208B1 (en) * 1997-07-16 2001-12-11 Board Of Regents, The University Of Texas System Methods for determining gluconeogenesis, anapleurosis and pyruvate recycling
US6482853B1 (en) 2000-07-12 2002-11-19 George A. Brooks Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery
US7256047B2 (en) * 2001-05-01 2007-08-14 Board Of Regents, The University Of Texas System Measurement of gluconeogenesis and intermediary metabolism using stable isotopes
CA2457523A1 (en) * 2001-08-06 2003-08-14 Vanderbilt University An apparatus and methods for using biological material to discriminate an agent
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
WO2004011426A2 (en) * 2002-07-30 2004-02-05 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
US20050027005A1 (en) * 2003-08-02 2005-02-03 Matthias Boldt Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner
WO2006119355A2 (en) * 2005-05-03 2006-11-09 Albert Einstein College Of Medicine Of Yeshiva University Mammalian hypothalamic nutrient modulation of glucose metabolism
US7503937B2 (en) * 2006-07-03 2009-03-17 Ossur Hf Prosthetic foot
CN101939011B (zh) * 2008-02-07 2012-10-10 雀巢产品技术援助有限公司 用于影响由剧烈的体力活动中恢复的组合物和方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275136A1 (en) * 2005-05-25 2008-11-06 Alain Grynberg Use of Glycerol for Improving Cardiac Function
US20090285909A1 (en) * 2006-04-03 2009-11-19 Leverve Xavier M Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BOUZAT PIERRE ET AL: "Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain.", INTENSIVE CARE MEDICINE MAR 2014, vol. 40, no. 3, March 2014 (2014-03-01), pages 412 - 421, XP009191029, ISSN: 1432-1238 *
C. BERGER ET AL: "Neurochemical Monitoring of Glycerol Therapy in Patients With Ischemic Brain Edema", STROKE, vol. 36, no. 2, 1 February 2005 (2005-02-01), US, pages e4 - e6, XP055289143, ISSN: 0039-2499, DOI: 10.1161/01.STR.0000151328.70519.e9 *
CAROLE BERTHET ET AL: "Neuroprotective role of lactate after cerebral ischemia", JOURNAL OF CEREBRAL BLOOD FLOW & METABOLISM, vol. 29, no. 11, 1 November 2009 (2009-11-01), US, pages 1780 - 1789, XP055288957, ISSN: 0271-678X, DOI: 10.1038/jcbfm.2009.97 *
HOLLOWAY R ET AL: "Effect of lactate therapy upon cognitive deficits after traumatic brain injury in the rat", ACTA NEUROCHIRURGICA ; THE EUROPEAN JOURNAL OF NEUROSURGERY, SPRINGER-VERLAG, VI, vol. 149, no. 9, 30 July 2007 (2007-07-30), pages 919 - 927, XP019544456, ISSN: 0942-0940, DOI: 10.1007/S00701-007-1241-Y *
KING P ET AL: "INTRAVENOUS LACTATE PREVENTS CEREBRAL DYSFUNCTION DURING HYPOGLYCAEMIA IN INSULIN-DEPENDENT DIABETES MELLITUS", CLINICAL SCIENCE, BIOCHEMICAL SOCIETY AND THE MEDICAL RESEARCH SOCIETY, LONDON, GB, vol. 94, no. 2, 1 February 1998 (1998-02-01), pages 157 - 163, XP009034382, ISSN: 0143-5221 *
LARS W. ANDERSEN ET AL: "Etiology and Therapeutic Approach to Elevated Lactate Levels", MAYO CLINIC PROCEEDINGS, vol. 88, no. 10, 1 October 2013 (2013-10-01), US, pages 1127 - 1140, XP055288931, ISSN: 0025-6196, DOI: 10.1016/j.mayocp.2013.06.012 *
THOMAS C. GLENN ET AL: "Endogenous Nutritive Support after Traumatic Brain Injury: Peripheral Lactate Production for Glucose Supply via Gluconeogenesis", JOURNAL OF NEUROTRAUMA., vol. 32, no. 11, 1 June 2015 (2015-06-01), US, pages 811 - 819, XP055288969, ISSN: 0897-7151, DOI: 10.1089/neu.2014.3482 *
THOMAS C. GLENN ET AL: "Lactate: Brain Fuel in Human Traumatic Brain Injury: A Comparison with Normal Healthy Control Subjects", JOURNAL OF NEUROTRAUMA., vol. 32, no. 11, 1 June 2015 (2015-06-01), US, pages 820 - 832, XP055288968, ISSN: 0897-7151, DOI: 10.1089/neu.2014.3483 *

Also Published As

Publication number Publication date
WO2014066628A3 (en) 2014-08-28
EP2912161A2 (en) 2015-09-02
AU2018229477A1 (en) 2018-10-04
JP2016502654A (ja) 2016-01-28
KR20150076229A (ko) 2015-07-06
AU2013334526B2 (en) 2018-06-14
JP2020101549A (ja) 2020-07-02
EP3505167A1 (en) 2019-07-03
WO2014066628A2 (en) 2014-05-01
AU2013334526A1 (en) 2015-06-11
KR102172971B1 (ko) 2020-11-03
CA2889348A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
EP2836270A4 (en) SYSTEMS AND METHODS RELATED TO THE TREATMENT OF BACK PAIN
EP2863858A4 (en) PATIENT DISPOSAL SYSTEMS AND METHOD OF USE
IL242825B (en) Systems and methods for diagnosis of depression and other medical conditions
HK1206037A1 (en) Human antibodies to gfr3 and methods of use thereof gfr3
IL239353A0 (en) Continuous production unit and methods for using it
EP2811897A4 (en) MEDICAL TERMINAL AND APPLICATION METHOD
EP2967579A4 (en) MULTILAYER EXTENSIBLE BRAIDED DEVICES AND METHODS OF USE
EP2858610A4 (en) THERMOTHERAPY SYSTEM AND METHOD OF USE
EP2838444A4 (en) EXPANDABLE OCCLUSION DEVICES AND METHODS OF USE
EP2856421A4 (en) SYSTEMS AND METHODS FOR TRANSPARENT MEDICAL TREATMENT DELIVERY
EP2906127A4 (en) SYSTEMS AND METHOD FOR ANCHORING MEDICAL DEVICES
GB201220219D0 (en) System and method of image reconstruction
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
EP2873239A4 (en) MONITORING SYSTEM AND USE METHOD THEREFOR
EP2864004A4 (en) DEVICE WITH ADAPTABLE DEBATMENT LENGTH, AND METHOD OF USE
GB2500588B (en) Systems and methods of hyperthermal treatment
IL233746B (en) A modular bioengineering and medical system
EP2825363A4 (en) FLEXIBLE MEDICAL ARTICLE AND METHOD FOR MANUFACTURING THE SAME
GB201200948D0 (en) Funeral urn system and method of using same
HK1207966A1 (en) Dietary and nutritional compositions and methods of use
EP2931351A4 (en) SYSTEMS AND METHOD FOR ANCHORING MEDICAL DEVICES
GB201408351D0 (en) Manufacture method and manufacture system of medical sleeve
HK1210008A1 (en) Systems and methods for treatment of sleep apnea
EP2814413A4 (en) BONE FIXING ELEMENT AND METHODS OF USE
HK1207953A1 (en) An enhanced therapeutic stimulus system and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150522

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20160727

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/047 20060101AFI20160721BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170329

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20190115